Clinical Results of the Verapamil in Hypertension and Atherosclerosis Study - VHAS

Description:

This was a multicenter, randomized, double-blind parallel-group trial designed to compare the efficacy and safety of prolonged treatment with slow-release verapamil versus chlorthalidone among patients with essential hypertension.